Fritz Blatter

Title: The Innovations of Fritz Blatter

Introduction

Fritz Blatter is a notable inventor based in Reinach, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of endothelin receptor antagonists. His work has led to advancements that may have important implications for various medical conditions.

Latest Patents

Fritz Blatter holds a patent for "Crystalline forms of a pyridinyl-sulfonamide and their use as endothelin receptor antagonists." This patent describes crystalline forms A and B of 5-methyl-pyridine-2-sulfonic acid [6-methoxy-5-(2-methoxy-phenoxy)-2-pyridin-4-yl-pyrimidin-4-yl]-amide of formula (I). Notably, form B is recognized as the most stable form. Additionally, this compound can form solvates with various solvents, including ethanol, acetone, tetrahydrofuran, methanol, isopropanol, 2-butanone, and dichloromethane.

Career Highlights

Fritz Blatter is associated with Speedel Pharma AG, a company that focuses on innovative pharmaceutical solutions. His work at Speedel Pharma AG has been instrumental in advancing research and development in the pharmaceutical industry.

Collaborations

Fritz has collaborated with notable colleagues such as Thierry Briand and Alexander Bilz. Their combined expertise has contributed to the success of various projects within the company.

Conclusion

Fritz Blatter's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his importance as an inventor. His work continues to influence advancements in medical research and development.